European Thyroid Journal

European Thyroid Journal is the open-access official journal of the European Thyroid Association, published by Bioscientifica and covering basic, translational and clinical thyroidology since 2012, with a 2025 Journal Impact Factor of 4.9.《欧洲甲状腺杂志》（European Thyroid Journal）是欧洲甲状腺协会的开放获取会刊，由（Bioscientifica）出版，2012 年创刊，覆盖基础、转化与临床甲状腺学，2025 年期刊影响因子为 4.9。

Scope

• The journal publishes original research in basic, translational and clinical thyroidology.刊物发表基础、转化与临床甲状腺学的原创研究。
• Contributions range from molecular and cellular biology to immunology and biochemistry.稿件范围从分子与细胞生物学延伸至免疫学与生物化学。
• Physiology and pathology are both represented.生理学与病理学均在覆盖之列。
• Paediatric and adult thyroid disease are covered, with a special focus on thyroid cancer.覆盖儿童与成人甲状腺疾病，并特别聚焦甲状腺癌。
• Reviews by recognised experts highlight especially active areas of current research.由知名专家撰写的综述评述当前研究的热点领域。
• The journal publishes formal guidelines produced and endorsed by the European Thyroid Association.刊物发表由欧洲甲状腺协会制定并认可的正式指南。
• Its content is organised into basic, translational and clinical thyroidology sections.内容按基础甲状腺学、转化甲状腺学与临床甲状腺学三个栏目组织。

History

• The European Thyroid Association approved the launch in 2011 on a proposal from its then president Peter Laurberg, and Wilmar Wiersinga became the first editor-in-chief.欧洲甲状腺协会于 2011 年批准创办该刊，动议来自时任主席（Peter Laurberg），（Wilmar Wiersinga）出任首任主编。
• The first regular issue appeared in April 2012, after a launch issue carrying abstracts from the 2011 ETA meeting in Krakow.首期正式卷于 2012 年 4 月出版，此前曾以创刊号刊载 2011 年克拉科夫欧洲甲状腺协会年会的摘要。^[1]
• Karger published the journal from its 2011 launch issue through 2021, initially as a quarterly.自 2011 年创刊号起至 2021 年，刊物由（Karger）出版，最初为季刊。
• It moved to six issues a year in 2017.2017 年起改为每年 6 期。
• From January 2022 the journal transferred to Bioscientifica and became fully open access, online only.2022 年 1 月起转由（Bioscientifica）出版，并改为完全开放获取、仅在线发行。^[2]
• Its 2025 Journal Impact Factor is 4.9, after 4.3 in 2024, 4.084 in 2022 and 4.209 in 2021.2025 年期刊影响因子为 4.9，此前 2024 年为 4.3，2022 年为 4.084，2021 年为 4.209。

Editors

• Luca Persani, professor of endocrinology at the University of Milan and head of endocrine and metabolic diseases at Istituto Auxologico Italiano, is editor-in-chief.现任主编为米兰大学内分泌学教授、（Istituto Auxologico Italiano）内分泌与代谢病科主任（Luca Persani）。
• He succeeded Simon Pearce at the end of 2023, after Pearce had led the journal since 2019.他于 2023 年底接替（Simon Pearce）；后者自 2019 年起执掌该刊。
• Seventeen associate editors support the editor-in-chief, with portfolios spanning basic, translational, clinical, paediatric and surgical thyroidology.17 位副编辑协助主编，分工覆盖基础、转化、临床、儿科与外科甲状腺学。
• They include Anita Boelen, Camille Buffet, Stine Linding Andersen, Marco Medici, Caterina Mian, Eric Mirallie and Mingzhao Xing.其中包括（Anita Boelen）、（Camille Buffet）、（Stine Linding Andersen）、（Marco Medici）、（Caterina Mian）、（Eric Mirallie）与（Mingzhao Xing）。
• The editorial board draws members from Europe, North and South America, Asia and Australia.编委会成员来自欧洲、北美与南美、亚洲及澳大利亚。
• Submissions are triaged by editors and then reviewed by two independent referees under a single anonymous model.稿件先经编辑初筛，再由两位独立审稿人以单盲方式评审。
• New submissions may be sent in any recognisable manuscript format through ScholarOne, and the journal aims to decide on reviewed papers within a month.新稿可依任意可识别的稿件格式经（ScholarOne）提交，刊物力求在一个月内对送审稿件作出决定。